Pasar al contenido principal

Antibiotic resistance in the maternal-infant microbiota

JDC2022-050269-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Juan de la Cierva
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Human milk metals and metalloids shape infant microbiota

  • Flores Ventura, Eduard
  • Bernabeu, Manuel
  • Callejón-Leblic, Belén
  • Cabrera-Rubio, Raul
  • Yeruva, Laxmi
  • Estañ-Capell, Javier
  • Martinez-Costa, Cecilia
  • García-Barrera, Tamara
  • Collado, Maria Carmen
[EN] Background: The profile of metal(loid)s in human milk is essential for infant growth and development, yet its impact on the development of the infant microbiota remains unclear. Elements, such as manganese, zinc, iron or copper, play crucial roles in influencing infant health. Aim: To investigate the metal(loid) content within human milk and its influence on the infant's gut microbiota within the first 2 months after birth. Methods: Human milk samples and infant stool samples from 77 mother¿infant dyads in the MAMI cohort were collected at two time points: the early transitional stage and the mature stage. Metallomic profiling of human milk was conducted using inductively coupled plasma-mass spectrometry (ICP-MS). The infant gut microbiota was profiled through 16S rRNA amplicon sequencing and maternal¿infant clinical data were available. Spearman's rank correlation coefficientsprovided insights into metal(loid)¿microbiota relationships. Results: Independent cross-sectional analyses of mother¿infant pairs at two time points, significant variations in metal concentrations and differences in microbial abundances and diversities were observed. Notably, Bifidobacterium genus abundance was higher during the mature lactation stage. During early lactation, we found a significant positive correlation between infant gut Corynebacterium and human milk nickel concentrations, and negative correlations between Veillonella spp. and antimony, and Enterobacter spp. and copper. Additionally, Simpson's diversity was negatively correlated with iron. In the mature lactation stage, we identified eleven significant correlations between metals and microbiota. Notably, Klebsiella genus showed multiple negative correlations with iron, antimony, and vanadium. Conclusion: Our study highlights the significance of metal(loid)¿microbiota interactions in early infant development, indicating that infant gut Klebsiella genus may be particularly vulnerable to fluctuations in metal(loid) levels present in human milk, when compared to other genera. Future research should explore these interactions at a strain level and the implications on infant health and development. This trial was registered as NCT03552939., The authors would like to thank the families involved in the MAMI study, as well as all the members of the MAMI cohort study. This research was supported by the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (ERC starting grant no. 639226) and the Spanish Ministry of Science and Innovation (MAMI-Plus ref. PID2022-139475OB-I00); PID2021-123073NB-C21 from the Spanish Ministry of Science and Innovation (MICIN); the Generacion del Conocimiento (MCI/AEI/FEDER "Una manera de hacer Europa"), and UHU-1256905 and UHU-202009 from the FEDER Andalusian Operative Program 2014-2020 (Ministry of Economy, Knowledge, Business and Universities, Regional Government of Andalusia, Spain). E.F.V. is grateful for the predoctoral grant awarded by the Spanish Ministry of Science and Innovation and thanks the European Social Fund Plus (ESF+) for the training of doctors within the framework of the State Plan for Scientific, Technical and Innovation Research 2021-2023 (ref. CEX2021-001189-S-20-1). M.B. is grateful for the post-PhD grant "Juan de la Cierva" (ref. JDC2022-050269-I) supported by the Spanish government MCIU/AEI and the European Union "NextGenerationEU"/PRTR. R.C.R. acknowledges the support from the Generalitat-Valenciana for the grant of the Plan GenT project (CDEIGENT 2020). IATA-CSIC authors also acknowledge the Spanish government MCIN/AEI to the Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

From the Microbiota to Health: The Influence of Diet, Analytical Methods, and Regulatory Challenges

  • Baizan Urgell, Martina
  • Bernabeu, Manuel
  • Enríquez Belenguer, Ana
  • Flores Ventura, Eduard
  • Navarro Lleó, Noemi
  • Rodríguez, Aroa
  • Samarra, Anna
  • Valls Verdoy, Anna
  • Cabrera-Rubio, Raúl
[EN] The study of the intestinal microbiota is highly relevant in understanding human health and its relationship with a wide range of diseases. The microbiota, consisting of a complex ecosystem of microorganisms, plays a crucial role in essential functions such as immunomodulation and metabolism. Alterations in this system, known as dysbiosis, are linked to pathologies such as inflammatory bowel diseases, metabolic disorders, and psychiatric conditions. Recent advances in analytical tools have not only allowed the characterization of the microbiota's composition but also an understanding of its functionality and interactions with the host. This article examines the latest methodologies for analysing the microbiota, including 16S ribosomal RNA sequencing, shotgun metagenomics, and techniques such as metabolomics and metaproteomics, highlighting their advantages and limitations. Additionally, the significant impact of diet on the composition and functionality of the microbiota is discussed. The influences of ultra-processed foods and fibre-rich diets, and how these can modify the microbial balance, are addressed. Furthermore, the commercialization of microbiota analysis is explored, which despite its popularity and promises of health benefits, faces criticism for the lack of regulation and standardization. This scenario reinforces the need for a stricter regulatory framework to ensure the reliability and safety of these analyses. In conclusion, while microbiota studies offer promising prospects for the development of personalized therapies and the improvement of intestinal and overall health, they also present significant challenges that require a rigorous and regulated approach to maximize their clinical and therapeutic potential. The article emphasizes the importance of a personalized approach in managing the microbiota, considering individual variability and environmental factors., [ES] El estudio de la microbiota intestinal tiene una gran relevancia en la comprensión de la salud humana y su relación con diversas enfermedades. La microbiota, compuesta por un complejo ecosistema de microorganismos, juega un papel crucial en funciones esenciales como la inmunomodulación y el metabolismo. Las alteraciones en este sistema, conocidas como disbiosis, están vinculadas a patologías como enfermedades inflamatorias intestinales, trastornos metabólicos y psiquiátricos. Avances recientes en herramientas analíticas han permitido no solo caracterizar la composición de la microbiota sino también entender su funcionalidad y las interacciones con el huésped. Este artículo examina las metodologías más recientes para el análisis de la microbiota, incluyendo la secuenciación de ARN ribosomal 16S, metagenómica completa, y técnicas como la metabolómica y la metaproteómica, destacando sus ventajas y limitaciones. Además, se discute el impacto significativo de la dieta en la composición y funcionalidad de la microbiota. Se abordan las influencias de los alimentos ultraprocesados y las dietas ricas en fibra, y cómo estas pueden modificar el equilibrio microbiano. Por otra parte, se explora la comercialización de análisis de microbiota que,, pese a su popularidad y promesas de beneficios para la salud, enfrentan críticas por la falta de regulación y estandarización. Este escenario refuerza la necesidad de un marco regulatorio más estricto para garantizar la fiabilidad y seguridad de estos análisis. En conclusión, mientras que los estudios de microbiota ofrecen perspectivas prometedoras para el desarrollo de terapias personalizadas y la mejora de la salud intestinal y general, también presentan desafíos significativos que requieren un enfoque riguroso y regulado para maximizar su potencial clínico y terapéutico. El artículo subraya la importancia de un enfoque personalizado en el manejo de la microbiota, considerando la variabilidad individual y los factores ambientales., Este trabajo fue financiado por el Ministerio de Ciencia e Innovación de España y el Fondo Social Europeo Plus (FSE+) (subvención CEX2021-001189-S-20-1); por el Ministerio de Ciencia, Innovación y Universidades de España / Agencia Estatal de Investigación y la Unión Europea “NextGenerationEU”/PRTR (subvención JDC2022-050269-I); por la Generalitat Valenciana (CDEIGENT 2020, INNEST/2023/337, ACIF/2021) y por el programa Centro de Excelencia Severo Ochoa (CEX2021-001189-S / MCIN / AEI / 10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed